AI in Healthcare

Today's Stories

1. 1

   Pfizer partners with AI startup to speed up antibody drug development

   Pfizer signed a licensing deal with Chai Discovery, an AI startup that uses artificial intelligence to design antibody drugs faster than traditional methods. The partnership gives Pfizer early access to Chai's new AI models that can predict how antibodies will work against diseases. Antibodies are proteins that fight infections and are used in many modern medicines.

   This could lead to faster development of new treatments for cancer, autoimmune diseases, and infections that currently take years to bring to market.

2. 2

   Abridge expands AI medical note-taking into insurance and drug trials

   Abridge, valued at $5.3 billion, converts doctor-patient conversations into medical records using AI and is now expanding beyond note-taking. The company is moving into insurance billing, drug trial data collection, and real-time insurance claim processing with backing from NVIDIA and Eli Lilly. The service currently saves doctors hours of paperwork after each patient visit.

   Patients may see faster insurance approvals and billing, while doctors spend less time on administrative tasks and more time on patient care.

3. 3

   Japanese pharma company Nxera joins AI drug discovery consortium

   Nxera Pharma joined OpenFold, a nonprofit research group that develops open-source AI tools for drug discovery alongside Amazon Web Services, Microsoft, and NVIDIA. The consortium shares AI software that helps predict how proteins fold, which is crucial for designing new medicines. OpenFold aims to make these powerful AI tools available to researchers worldwide rather than keeping them proprietary.

   More pharmaceutical companies gaining access to advanced AI tools could accelerate the development of new treatments and potentially lower drug costs.

4. 4

   Developer creates local AI for medical speech recognition on personal devices

   A developer fine-tuned NVIDIA's Parakeet AI model to transcribe medical conversations on personal computers and phones without sending audio to the cloud. The system, called Omi Med STT, can accurately transcribe medical terminology and drug names while keeping patient conversations private on the device. It works on Mac, Windows, and Linux computers.

   Doctors could soon transcribe patient visits privately on their own devices without privacy concerns about sending recordings to external servers.

5. 5

   AI drug discovery leaders warn about US funding cuts

   Executives from pharmaceutical AI companies including Lila Sciences and NVIDIA warned that proposed US health research funding cuts could allow other countries to dominate AI-powered drug discovery. They argue that the combination of AI and biology will determine which countries lead in developing new medicines for decades. The warning came during discussions about maintaining America's competitive edge in medical innovation.

   Reduced funding could mean fewer breakthrough medicines developed in the US and potential delays in treatments reaching American patients first.